Silexion Therapeutics Ltd. (SLXN) NASDAQ

7.36

-0.04(-0.54%)

Updated at August 14 04:00PM

Currency In USD

Valuation

Market Cap188.09M
Enterprise Value191.39M
P/E Ratio-2.97
PEG Ratio-0.49
Price/Sales Ratio0
Price/Book Ratio19.29
Enterprise/Revenue0
Enterprise/EBITDA-0.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-2.02
Return On Equity2.77

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-16.43M
Net Income16.51M
Diluted EPS-2.64

Balance Sheet

Total Cash6.15M
Total Cash/Share0.91
Total Debt3.48M
Total Debt/Equity1.35
Current Ratio3.22
Book Value Per Share0.38

Price History

52-Week Change-97.2
52-Week High181.35
52-Week Low3.11
Moving Average 50 Days11.89
Moving Average 200 Days16.89

Statistics

Average Volume91,255
Shares Outstanding579,493
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateJuly 29, 2025